Actualités
- Details
Optimization of targeted internal radiotherapy against VCAM-1 for brain metastases using predictive dosimetry (OPTADOM)
CERMN, Caen and ISTCT UMR 6030 Caen, Normandy, FRANCE
Prof. Thomas Cailly, Dr. Samuel Valable, and Dr. Aurélien Corroyer-Dulmont
Applications must include a detailed CV, at least two references (with contact details), and a one-page cover letter.
Applications should be sent by email to Pr Thomas Cailly, to Dr
The deadline for applications is November 1st, 2025.
Shortlisted candidates will be contacted mid of November.
More information ici
- Details
An article from out research unit has just been published in Biomedicine & Pharmacotherapy (IF 7.5)
Amphiregulin reflects brain metastasis progression and leads to PD-L1 expression in non-small cell lung cancer cells
D. Leite Ferreira*, T. Biojout*, C. Bazille, M. Guyot, L. Malandain, L. Charrier, J. Toutain, E. Peres, S. Valable, J. Madelaine, J. Levallet, G. Levallet**, E. Bergot**
*,** equal contribution
Biomed. Pharmacother. (2025) https://doi.org/10.1016/j.biopha.2025.118600
Licence CC-BY
- Details
An article from our research unit has just been published in Redox Report (IF 7.4)
Manganese (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) represses sulfide:quinone oxidoreductase expression and targets the sulfido-redox system in glioblastoma models.
Malard E., Bernay B., Toutain J, Ballesta S, Lévêque M, Pontin J, Valable S, Bernaudin M, Chatre L.
Redox Report 30(1) 2025
https://doi.org/10.1080/13510002.2025.2557081

- Details
Tiphaine Biojout will defend her thesis on Thursday September 25 at 9:30 a.m. Jules Horowitz room, Cyceron center.



Français (France)
English (United Kingdom) 
